Biodegradable Polymer Evermine 50™ Everolimus Eluting Coronary Stent System With Ultrathin (50 Μm) Strut

Integrative Clinical Medicine
doi 10.15761/icm.1000128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Open Access Text Pvt, Ltd.

Related search

Biodegradable Polymer-Coated Thin Strut Sirolimus-Eluting Stent vs. Durable Polymer-Coated Everolimus-Eluting Stent in the Diabetic Population

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2013English

Safety and Efficacy of Biodegradable Polymer-Coated Thin Strut Sirolimus-Eluting Stent vs. Durable Polymer-Coated Everolimus-Eluting Stent in Patients With Acute Myocardial Infarction

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2018English

Pmd16 - Health Economic Evaluation of an Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable Polymer Everolimus-Eluting Stent

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Ultrathin Strut Biodegradable-Polymer Sirolimus-Eluting Stents: Being Wary or Going With the Flow?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Randomised Comparison of a Biodegradable Polymer Ultra-Thin Sirolimus-Eluting Stent Versus a Durable Polymer Everolimus-Eluting Stent in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Trial

EuroIntervention
MedicineCardiovascular MedicineCardiology
2018English

One-Year Clinical Outcomes of Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stent System in Patients With Coronary Artery Disease

World Journal of Cardiovascular Diseases
2017English

Preliminary Clinical Outcomes After Implantation of Newer-Generation Biodegradable Polymer-Coated Everolimus-Eluting Stent in “Real-World” Patients With Coronary Artery Disease

World Journal of Cardiovascular Diseases
2016English

Biolimus-Eluting Biodegradable Polymer-Coated Stent Versus Durable Polymer-Coated Sirolimus-Eluting Stent in Unselected Patients Receiving Percutaneous Coronary Intervention (SORT OUT V): A Randomised Non-Inferiority Trial

The Lancet
Medicine
2013English

Everolimus-Eluting Stent Platforms in Percutaneous Coronary Intervention: Comparative Effectiveness and Outcomes

Medical Devices: Evidence and Research
MedicineBiomedical Engineering
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy